Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation. / Hornum, Mads; Burton, Christopher M; Iversen, Martin; Hovind, Peter; Hilsted, Linda; Feldt-Rasmussen, Bo.

In: Nephrology, Dialysis, Transplantation, Vol. 22, No. 12, 2007, p. 3616-22.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hornum, M, Burton, CM, Iversen, M, Hovind, P, Hilsted, L & Feldt-Rasmussen, B 2007, 'Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation.', Nephrology, Dialysis, Transplantation, vol. 22, no. 12, pp. 3616-22. https://doi.org/10.1093/ndt/gfm478

APA

Hornum, M., Burton, C. M., Iversen, M., Hovind, P., Hilsted, L., & Feldt-Rasmussen, B. (2007). Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation. Nephrology, Dialysis, Transplantation, 22(12), 3616-22. https://doi.org/10.1093/ndt/gfm478

Vancouver

Hornum M, Burton CM, Iversen M, Hovind P, Hilsted L, Feldt-Rasmussen B. Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation. Nephrology, Dialysis, Transplantation. 2007;22(12):3616-22. https://doi.org/10.1093/ndt/gfm478

Author

Hornum, Mads ; Burton, Christopher M ; Iversen, Martin ; Hovind, Peter ; Hilsted, Linda ; Feldt-Rasmussen, Bo. / Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation. In: Nephrology, Dialysis, Transplantation. 2007 ; Vol. 22, No. 12. pp. 3616-22.

Bibtex

@article{49c8ee70acc611ddb538000ea68e967b,
title = "Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation.",
abstract = "BACKGROUND: The nephrotoxity of calcineurin inhibitors in lung-transplanted patients is well described, but previous studies have estimated rather than directly measured glomerular filtration rate (GFR). This study describes the decline of measured GFR in a large cohort of lung-transplanted patients from a national centre, and the correlation between measured and calculated GFR. METHODS: All lung-transplanted patients 1992-2004 (n = 390) were included in a longitudinal analysis. Seven patients were excluded due to retransplantation. Pre- and post-transplant parameters included (51)Cr-labelled EDTA clearance (mGFR) and the Cockcroft-Gault calculated clearance (cGFR). Trough cyclosporine levels (C0) and demographic and transplant information were also included in the analysis. RESULTS: A total of 66959 C0 and serum creatinine and 1945 mGFR measurements pertaining to 383 patients were included in the analysis. Pre-transplant mGFR was significantly lower with respect to recipient age over 60 years; and patients with a referral diagnosis of pulmonary hypertension had a lower mGFR and higher baseline serum creatinine levels than patients with emphysematous disease (P < 0.05). There were linear correlations between log(10) mean interval serum creatinine and log(2) mGFR at all time points pre- and post-transplantation (P < 0.0001, Spearman correlation coefficient = -0.81) and between log(2) cGFR and log(2) mGFR (P < 0.0001, Spearman correlation coefficient = 0.81), however, the agreement between mGFR and cGFR was poor (-2.7 +/- 38.6 ml/min). A simplified repeated measure ANOVA model describing post-transplant GFR over time demonstrated a 54% decline in mGFR within the first 6 months post-transplant. Pre-transplant mGFR was an important determinant of 6 month post-transplantation mGFR. Increasing mean C0, body mass index and early acute renal failure were independent risk factors for a more rapid decline in post-transplant mGFR. CONCLUSION: mGFR decreases dramatically during the first 6 months after lung-transplantation. Avoidance of high dose calcineurin inhibition may postpone the onset of post-transplant end-stage renal failure.",
author = "Mads Hornum and Burton, {Christopher M} and Martin Iversen and Peter Hovind and Linda Hilsted and Bo Feldt-Rasmussen",
note = "Keywords: Adult; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Lung Transplantation; Male; Middle Aged",
year = "2007",
doi = "10.1093/ndt/gfm478",
language = "English",
volume = "22",
pages = "3616--22",
journal = "Nephrology, Dialysis, Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "12",

}

RIS

TY - JOUR

T1 - Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantation.

AU - Hornum, Mads

AU - Burton, Christopher M

AU - Iversen, Martin

AU - Hovind, Peter

AU - Hilsted, Linda

AU - Feldt-Rasmussen, Bo

N1 - Keywords: Adult; Chromium Radioisotopes; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Lung Transplantation; Male; Middle Aged

PY - 2007

Y1 - 2007

N2 - BACKGROUND: The nephrotoxity of calcineurin inhibitors in lung-transplanted patients is well described, but previous studies have estimated rather than directly measured glomerular filtration rate (GFR). This study describes the decline of measured GFR in a large cohort of lung-transplanted patients from a national centre, and the correlation between measured and calculated GFR. METHODS: All lung-transplanted patients 1992-2004 (n = 390) were included in a longitudinal analysis. Seven patients were excluded due to retransplantation. Pre- and post-transplant parameters included (51)Cr-labelled EDTA clearance (mGFR) and the Cockcroft-Gault calculated clearance (cGFR). Trough cyclosporine levels (C0) and demographic and transplant information were also included in the analysis. RESULTS: A total of 66959 C0 and serum creatinine and 1945 mGFR measurements pertaining to 383 patients were included in the analysis. Pre-transplant mGFR was significantly lower with respect to recipient age over 60 years; and patients with a referral diagnosis of pulmonary hypertension had a lower mGFR and higher baseline serum creatinine levels than patients with emphysematous disease (P < 0.05). There were linear correlations between log(10) mean interval serum creatinine and log(2) mGFR at all time points pre- and post-transplantation (P < 0.0001, Spearman correlation coefficient = -0.81) and between log(2) cGFR and log(2) mGFR (P < 0.0001, Spearman correlation coefficient = 0.81), however, the agreement between mGFR and cGFR was poor (-2.7 +/- 38.6 ml/min). A simplified repeated measure ANOVA model describing post-transplant GFR over time demonstrated a 54% decline in mGFR within the first 6 months post-transplant. Pre-transplant mGFR was an important determinant of 6 month post-transplantation mGFR. Increasing mean C0, body mass index and early acute renal failure were independent risk factors for a more rapid decline in post-transplant mGFR. CONCLUSION: mGFR decreases dramatically during the first 6 months after lung-transplantation. Avoidance of high dose calcineurin inhibition may postpone the onset of post-transplant end-stage renal failure.

AB - BACKGROUND: The nephrotoxity of calcineurin inhibitors in lung-transplanted patients is well described, but previous studies have estimated rather than directly measured glomerular filtration rate (GFR). This study describes the decline of measured GFR in a large cohort of lung-transplanted patients from a national centre, and the correlation between measured and calculated GFR. METHODS: All lung-transplanted patients 1992-2004 (n = 390) were included in a longitudinal analysis. Seven patients were excluded due to retransplantation. Pre- and post-transplant parameters included (51)Cr-labelled EDTA clearance (mGFR) and the Cockcroft-Gault calculated clearance (cGFR). Trough cyclosporine levels (C0) and demographic and transplant information were also included in the analysis. RESULTS: A total of 66959 C0 and serum creatinine and 1945 mGFR measurements pertaining to 383 patients were included in the analysis. Pre-transplant mGFR was significantly lower with respect to recipient age over 60 years; and patients with a referral diagnosis of pulmonary hypertension had a lower mGFR and higher baseline serum creatinine levels than patients with emphysematous disease (P < 0.05). There were linear correlations between log(10) mean interval serum creatinine and log(2) mGFR at all time points pre- and post-transplantation (P < 0.0001, Spearman correlation coefficient = -0.81) and between log(2) cGFR and log(2) mGFR (P < 0.0001, Spearman correlation coefficient = 0.81), however, the agreement between mGFR and cGFR was poor (-2.7 +/- 38.6 ml/min). A simplified repeated measure ANOVA model describing post-transplant GFR over time demonstrated a 54% decline in mGFR within the first 6 months post-transplant. Pre-transplant mGFR was an important determinant of 6 month post-transplantation mGFR. Increasing mean C0, body mass index and early acute renal failure were independent risk factors for a more rapid decline in post-transplant mGFR. CONCLUSION: mGFR decreases dramatically during the first 6 months after lung-transplantation. Avoidance of high dose calcineurin inhibition may postpone the onset of post-transplant end-stage renal failure.

U2 - 10.1093/ndt/gfm478

DO - 10.1093/ndt/gfm478

M3 - Journal article

C2 - 17675330

VL - 22

SP - 3616

EP - 3622

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

SN - 0931-0509

IS - 12

ER -

ID: 8464187